UY36200A - Conjunto de biomarcadores específicos para diagnóstico no invasivo de cáncer de hígado - Google Patents
Conjunto de biomarcadores específicos para diagnóstico no invasivo de cáncer de hígadoInfo
- Publication number
- UY36200A UY36200A UY0001036200A UY36200A UY36200A UY 36200 A UY36200 A UY 36200A UY 0001036200 A UY0001036200 A UY 0001036200A UY 36200 A UY36200 A UY 36200A UY 36200 A UY36200 A UY 36200A
- Authority
- UY
- Uruguay
- Prior art keywords
- liver cancer
- diagnosis
- specific biomarkers
- prognosis
- invasive diagnosis
- Prior art date
Links
Classifications
-
- G01N33/57585—
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/533—Production of labelled immunochemicals with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G01N33/57525—
-
- G01N33/5758—
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
- G01N33/6869—Interleukin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/56—Staging of a disease; Further complications associated with the disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Rheumatology (AREA)
- Rehabilitation Therapy (AREA)
- Bioinformatics & Computational Biology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14/321,870 US9885718B2 (en) | 2014-07-02 | 2014-07-02 | Specific biomarker set for non-invasive diagnosis of liver cancer |
| US14/321,867 US9506925B2 (en) | 2014-07-02 | 2014-07-02 | Specific biomarker set for non-invasive diagnosis of liver cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY36200A true UY36200A (es) | 2016-01-29 |
Family
ID=55019816
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY0001036200A UY36200A (es) | 2014-07-02 | 2015-07-01 | Conjunto de biomarcadores específicos para diagnóstico no invasivo de cáncer de hígado |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP3164711A4 (enExample) |
| JP (2) | JP2017520763A (enExample) |
| KR (1) | KR102086788B1 (enExample) |
| CN (2) | CN105319362B (enExample) |
| AU (2) | AU2014399919B2 (enExample) |
| CA (1) | CA2939912C (enExample) |
| MY (2) | MY195045A (enExample) |
| NZ (1) | NZ722492A (enExample) |
| SG (1) | SG11201606106SA (enExample) |
| TW (1) | TWI700493B (enExample) |
| UY (1) | UY36200A (enExample) |
| WO (1) | WO2016003479A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106383231B (zh) * | 2016-09-02 | 2020-03-17 | 四川大学 | 一种诊断肝癌的标记物组合及其应用 |
| GB201619954D0 (en) * | 2016-11-25 | 2017-01-11 | Oncimmune Ltd | Antibody assay |
| KR102175265B1 (ko) | 2019-03-13 | 2020-11-06 | 충남대학교산학협력단 | Txndc7을 포함하는 간세포암종 진단 또는 예후 예측용 바이오마커 조성물 |
| CN110646615B (zh) * | 2019-08-27 | 2021-07-13 | 南方医科大学 | 肝纤维化的生物学标志物、治疗靶点及其用途 |
| ES2987661T3 (es) | 2020-07-10 | 2024-11-15 | Guardant Health Inc | Métodos de detección de reordenamientos genómicos utilizando ácidos nucleicos libres de células |
| WO2023282916A1 (en) | 2021-07-09 | 2023-01-12 | Guardant Health, Inc. | Methods of detecting genomic rearrangements using cell free nucleic acids |
| CN113502328A (zh) * | 2021-05-27 | 2021-10-15 | 深圳市人民医院 | 检测样本中标志物表达水平的试剂在制备用于检测或诊断乳腺癌的试剂盒中的应用 |
| CN113777295B (zh) * | 2021-09-15 | 2024-03-19 | 江南大学 | 用于检测肿瘤标志物pd-l1的高灵敏度量子点探针、制备方法及应用 |
| CN113956344A (zh) * | 2021-10-14 | 2022-01-21 | 江南大学 | 一种新型治疗肝癌的fgf类似物及其应用 |
| CN114113611B (zh) * | 2021-12-13 | 2023-07-14 | 郑州大学 | 一种用于肝癌诊断的生物标志物及检测试剂盒 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6449562B1 (en) | 1996-10-10 | 2002-09-10 | Luminex Corporation | Multiplexed analysis of clinical specimens apparatus and method |
| US6893844B1 (en) * | 1998-09-22 | 2005-05-17 | Long Yu | DNA encoding a new human hepatoma derived growth factor and producing method thereof |
| US7387881B2 (en) * | 2001-09-19 | 2008-06-17 | The Regents Of The University Of Michigan | Detection and treatment of cancers of the liver |
| WO2003058201A2 (en) * | 2001-12-31 | 2003-07-17 | Quark Biotech, Inc. | Methods for identifying marker genes for cancer |
| GB0228900D0 (en) | 2002-12-11 | 2003-01-15 | Ml Lab Plc | Cancer Immunotherapy |
| JP3960614B2 (ja) * | 2003-08-31 | 2007-08-15 | 株式会社イムノディア | 抗ペプチド抗体測定法とペプチドワクチンのワクチン候補選択方法 |
| GB0406215D0 (en) * | 2004-03-19 | 2004-04-21 | Procure Therapeutics Ltd | Prostate stem cell |
| CA2567987A1 (en) * | 2004-06-18 | 2005-12-29 | Gabriele Pestlin | Use of protein pdx1 as a marker for breast cancer |
| JP5211315B2 (ja) * | 2006-07-25 | 2013-06-12 | 国立大学法人愛媛大学 | 腫瘍マーカ、腫瘍診断キットおよび腫瘍マーカの測定方法 |
| EP2187216B1 (en) * | 2007-08-10 | 2012-09-26 | Hyogo College Of Medicine | Novel liver cancer marker |
| US8512963B2 (en) * | 2009-11-25 | 2013-08-20 | The Johns Hopkins University | Detection and quantitation of full-length thioredoxin (TRX) and truncated thioredoxin (TRX 80) in complex samples |
| US9523680B2 (en) * | 2010-06-30 | 2016-12-20 | Ambergen, Inc. | Global Proteomic screening of random bead arrays using mass spectrometry imaging |
| JP5493130B2 (ja) * | 2010-08-25 | 2014-05-14 | 国立大学法人山口大学 | 自己抗体の検出方法 |
| WO2012115885A1 (en) * | 2011-02-22 | 2012-08-30 | Caris Life Sciences Luxembourg Holdings, S.A.R.L. | Circulating biomarkers |
| US20130130355A1 (en) | 2011-09-28 | 2013-05-23 | Armune Biosciences, Inc. | Method and system of particle-phage epitope complex |
-
2014
- 2014-07-31 EP EP14896556.9A patent/EP3164711A4/en not_active Withdrawn
- 2014-07-31 KR KR1020167032783A patent/KR102086788B1/ko not_active Expired - Fee Related
- 2014-07-31 WO PCT/US2014/049038 patent/WO2016003479A1/en not_active Ceased
- 2014-07-31 TW TW103126171A patent/TWI700493B/zh not_active IP Right Cessation
- 2014-07-31 MY MYPI2016002278A patent/MY195045A/en unknown
- 2014-07-31 JP JP2016571689A patent/JP2017520763A/ja active Pending
- 2014-07-31 AU AU2014399919A patent/AU2014399919B2/en not_active Ceased
- 2014-07-31 MY MYPI2017001446A patent/MY179845A/en unknown
- 2014-07-31 CA CA2939912A patent/CA2939912C/en active Active
- 2014-07-31 NZ NZ72249214A patent/NZ722492A/en not_active IP Right Cessation
- 2014-07-31 SG SG11201606106SA patent/SG11201606106SA/en unknown
-
2015
- 2015-07-01 CN CN201510379493.9A patent/CN105319362B/zh not_active Expired - Fee Related
- 2015-07-01 CN CN201710545890.8A patent/CN107478842B/zh not_active Expired - Fee Related
- 2015-07-01 UY UY0001036200A patent/UY36200A/es unknown
-
2017
- 2017-09-21 AU AU2017232129A patent/AU2017232129B2/en not_active Ceased
-
2020
- 2020-06-22 JP JP2020106731A patent/JP2020160082A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| CA2939912C (en) | 2019-04-16 |
| MY179845A (en) | 2020-11-18 |
| TW201602579A (zh) | 2016-01-16 |
| AU2014399919B2 (en) | 2019-10-24 |
| HK1248803A1 (zh) | 2018-10-19 |
| HK1224370A1 (zh) | 2017-08-18 |
| KR102086788B1 (ko) | 2020-03-09 |
| WO2016003479A1 (en) | 2016-01-07 |
| AU2017232129A1 (en) | 2017-10-12 |
| EP3164711A1 (en) | 2017-05-10 |
| AU2014399919A1 (en) | 2016-08-11 |
| CN107478842A (zh) | 2017-12-15 |
| CN107478842B (zh) | 2020-10-16 |
| TWI700493B (zh) | 2020-08-01 |
| EP3164711A4 (en) | 2018-05-23 |
| JP2017520763A (ja) | 2017-07-27 |
| KR20170021234A (ko) | 2017-02-27 |
| MY195045A (en) | 2023-01-04 |
| JP2020160082A (ja) | 2020-10-01 |
| NZ722492A (en) | 2019-09-27 |
| SG11201606106SA (en) | 2016-08-30 |
| CN105319362B (zh) | 2018-07-13 |
| AU2017232129B2 (en) | 2018-10-25 |
| CN105319362A (zh) | 2016-02-10 |
| CA2939912A1 (en) | 2016-01-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY36200A (es) | Conjunto de biomarcadores específicos para diagnóstico no invasivo de cáncer de hígado | |
| EP3606507A4 (en) | SEROLOGICAL BIOMARKERS FOR EARLY DIAGNOSIS OF LUNG CANCER | |
| MX368513B (es) | Métodos in vitro para el pronóstico, diagnóstico y diseño de una terapia de metástasis de cáncer de pulmón. | |
| EA201791578A1 (ru) | Панель биомаркеров для обнаружения рака | |
| EA201792497A1 (ru) | Антитела к gitr для диагностики злокачественной опухоли | |
| MX390772B (es) | Métodos para tratar cáncer y el uso de biomarcadores como predictor de sensibilidad clínica a terapias. | |
| MX383381B (es) | Métodos y composiciones para detectar proteínas mal plegadas. | |
| MX2017008421A (es) | Métodos terapéuticos, diagnósticos y pronósticos para el cáncer de vejiga. | |
| BR112016027475A2 (pt) | kit, dispositivo e método para a detecção de câncer pancreático | |
| BR112016029583A2 (pt) | ?kit ou dispositivo para a detecção de câncer esofágico e método de detecção? | |
| MX362041B (es) | Método para el pronóstico y tratamiento de cáncer metastásico de los huesos originado de cáncer de mama. | |
| BR112016029634A2 (pt) | kit, dispositivo e método para a detecção de câncer de fígado | |
| IL270717A (en) | Biomarkers for diagnosis of lung cancer | |
| BR112017003472A2 (pt) | anticorpos, fragmento fab de anticorpo e método para o tratamento de uma doença inflamatória | |
| MA39776A (fr) | Traitement du cancer avec des antagonistes de c-met et corrélation de ces derniers avec l'expression de hgf | |
| EA201790549A1 (ru) | Предиктивные и прогностические биомаркеры, связанные с антиангиогенной терапией злокачественной опухоли | |
| Leung et al. | Ovarian cancer biomarkers: current state and future implications from high-throughput technologies | |
| MX392040B (es) | Estandares de antigeno prostatico y sus usos. | |
| MX2017000840A (es) | Metodo para predecir el resultado de un tratamiento con aflibercept de un paciente que se sospecha que padece un cancer. | |
| WO2015082416A8 (en) | Novel rna-biomarkers for diagnosis of prostate cancer | |
| MX2016009450A (es) | Ensayo novedoso para detectar periostina humana. | |
| BR112017006593A2 (pt) | método para detectar câncer de ovário | |
| CY1119430T1 (el) | Anti-s100a7 αντισωματα για τη θεραπευτικη αγωγη και διαγνωση καρκινου | |
| MA40636A (fr) | Procédés pour détecter le cancer de la prostate | |
| MX2021003214A (es) | Metodos terapeuticos y de diagnostico para el cancer de vejiga. |